The Trustee for BLOODWORKS UNIT TRUST
Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets
- Conditions
- Reversal of Platelet Aggregation Inhibitors
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Bloodworks
- Target Recruit Count
- 10
- Registration Number
- NCT05111028
- Locations
- 🇺🇸
Bloodworks Northwest Research Institute, Seattle, Washington, United States
Von Willebrand Factor in Pregnancy (VIP) Study
- Conditions
- Von Willebrand Diseases
- Interventions
- Other: Use of a postpartum diary and additional blood drawsDrug: VWF replacement therapy with WilateOther: Use of a postpartum diary and additional blood draws.
- First Posted Date
- 2019-10-31
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Bloodworks
- Target Recruit Count
- 110
- Registration Number
- NCT04146376
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸Yale University, New Haven, Connecticut, United States
🇺🇸University of Miami, Miami, Florida, United States
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
- Conditions
- Platelet Dysfunction Due to DrugsBleedingPlatelet Dysfunction
- Interventions
- Drug: Autologous Platelet Transfusion (room-temperature-stored)Drug: Autologous Platelet Transfusion (cold-stored 5 days)Drug: Autologous Platelet Transfusion (cold-stored 10 days)Drug: Autologous Platelet Transfusion (cold-stored 15 days)
- First Posted Date
- 2018-12-27
- Last Posted Date
- 2020-07-14
- Lead Sponsor
- Bloodworks
- Target Recruit Count
- 60
- Registration Number
- NCT03787927
- Locations
- 🇺🇸
Bloodworks Northwest Research Institute, Seattle, Washington, United States
Joint Health Study
- Conditions
- Hemophilia B
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- Bloodworks
- Target Recruit Count
- 8
- Registration Number
- NCT03358836
- Locations
- 🇺🇸
Orthopaedic Institute for Children at University of California Los Angeles, Los Angeles, California, United States
🇺🇸University of California San Diego, San Diego, California, United States
🇺🇸Tulane University, New Orleans, Louisiana, United States
Comparison of Ideal vs. Actual Weight Base Factor Dosing
- Conditions
- Hemophilia A
- First Posted Date
- 2017-09-18
- Last Posted Date
- 2017-09-18
- Lead Sponsor
- Bloodworks
- Target Recruit Count
- 20
- Registration Number
- NCT03286153
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸Washington Center for Bleeding Disorders at Bloodworks Northwest, Seattle, Washington, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States
- Prev
- 1
- 2
- 3
- Next